The use of immunohistochemistry for evaluating the liver

W C Hall1, J L Rojko

  • 1Pathology Associates International, Frederick, Maryland 21701, USA.

Toxicologic Pathology
|January 1, 1996
PubMed

Insights

Immunohistochemistry aids in diagnosing liver infections and advancing toxicologic pathology research. This technique identifies cell types, detects disease markers, and clarifies mechanisms of lesion development.

Area of Science:

  • Immunohistochemistry applications in pathology and disease research.

Background:

  • Immunohistochemistry (IHC) is increasingly used for diagnosing infectious liver diseases in humans.
  • Its utility extends to experimental and toxicologic pathology, covering cell identification and functional changes.

Purpose of the Study:

  • To highlight the diverse applications of immunohistochemistry in pathology.
  • To emphasize its role in experimental research, diagnostics, and understanding disease mechanisms.

Main Methods:

  • Utilizing immunohistochemistry for cell phenotype and receptor identification.
  • Employing IHC to detect cytokine/chemokine production and enzyme induction.
  • Applying IHC for detecting carcinogenesis markers and oncofetal proteins.

Main Results:

  • Immunohistochemistry enables precise identification of cell types and their functions.
  • It detects novel antigens and oncogene products relevant to carcinogenesis.
  • IHC aids in diagnosing neoplasms and understanding developmental/toxicity studies.

Conclusions:

  • Immunohistochemistry is a versatile tool in toxicologic pathology.
  • Its application enhances the diagnosis of unique conditions.
  • IHC aids in elucidating mechanisms of lesion development when combined with other techniques.